Evidence map›Paper›PMID 33053857›Full record

ArticleJournal of clinical medicine2020

Prognostic Significance of Tumor Location in T2 Gallbladder Cancer: A Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) Database Analysis.

Seung Eun Lee, Yoo Shin Choi, Yong Hoon Kim, Jin Seok Heo, Chi-Young Jeong, Woo Jung Lee, Hyung Ii Seo, Yoo-Seok Yoon, Jin-Young Jang

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Seung Eun LeeDepartment of Surgery, Chung-Ang University College of Medicine, Seoul 06973, Korea.
Yoo Shin ChoiDepartment of Surgery, Chung-Ang University College of Medicine, Seoul 06973, Korea.
Yong Hoon KimDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu 42601, Korea.
Jin Seok HeoDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul 06351, Korea.
Chi-Young JeongDepartment of Surgery, Gyeongsang National University College of Medicine, Jinju, 52727, Korea.
Woo Jung LeeDepartment of Surgery, Yonsei University College of Medicine, Seoul 03722, Korea.
Hyung Ii SeoDepartment of Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan 49241, Korea.
Yoo-Seok YoonDepartment of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul 13620, Korea.
Jin-Young JangDepartment of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea.

Funding

Korean Association for the Hepato-Biliary-Pancreatic Surgery for "(KAHPBS-16-02) and by Korean Tumor Registry System (KOTUS) KAHPBS-16-02
6 · The paper itself

Abstract

backgroundT2 gallbladder cancer (GBC) is subdivided into T2a and T2b by the American Joint Committee on Cancer (AJCC) 8th edition. However; there is a lack of evidence for the prognostic significance of tumor location and validation with large-scale studies is needed. The aims of this study were to investigate the clinical features and clinical outcomes of T2 GBC according to tumor location and determine the prognostic significance of tumor location and an appropriate surgical strategy.

methodsBetween 2000 and 2014 the Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) database was used to identify and enroll a total 707 patients with pathologically diagnosed T2 GBC who underwent curative resection. Clinicopathological findings and long-term follow-up results were analyzed.

resultsThe incidence of lymph node metastasis in T2b was significantly higher than that of T2a tumors (37.9% vs. 29.5%,

conclusionsFor T2 GBC; tumor location was not an independent prognostic factor. Lymph node metastasis was a significant poor prognostic factor and adjuvant chemotherapy should be considered for the patients with lymph node metastasis.

Indexed as

carcinomagallbladderhepaticperitonealprognosis

Identifiers

PMID33053857
PMCPMC7600653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.